GLP-1 Titration Planner

Map your semaglutide or tirzepatide dose escalation with personalized dates for each step up, from your opening dose through maintenance.

GLP-1 titration

Dose escalation planner

Map your titration timeline with start dates for each step up.

GLP-1 receptor agonist for weight management

Wegovy

Semaglutide

Current

0.25mg

Weeks 1-4

Sep 3

2026

0.5mg

Weeks 5-8

Oct 1

2026

1mg

Weeks 9-12

Oct 29

2026

1.7mg

Weeks 13-16

Nov 26

2026

2.4mg

Week 17+ (Maintenance)

Dec 24

2026

Keep your dose schedule in Regimen with a reminder at each step.Add to Regimen

Standard FDA titration schedule. Your provider may adjust it based on your response.

This planner is for informational purposes only, so always double-check your result with a healthcare provider. Retatrutide is investigational and not yet FDA-approved, and the schedules shown are standard escalation paths your prescriber may adjust. We assume no liability for dosing errors.

The tool

How it works, what it tells you, what it doesn't.

The GLP-1 titration planner turns the standard FDA dose-escalation schedule into a personalized calendar. Pick your medication, set the date of your first dose, and it lays out every step up with the exact week range and start date, from your opening dose through maintenance. Titration exists to give your body time to adjust, which is what keeps nausea and other GI side effects manageable. The planner shows the default manufacturer schedule, so treat it as a map, not a prescription. Your provider may move faster or hold you on a step longer based on how you respond.

How to use it

How to Use the Titration Planner

  1. 01

    Select your medication

    Choose from Wegovy, Ozempic, Mounjaro, Zepbound, or Retatrutide.

  2. 02

    Enter your start date

    The date you started, or plan to start, your first dose.

  3. 03

    View your schedule

    See the exact week range and start date for every dose increase.

  4. 04

    Copy or track it

    Copy the full schedule, or track each step in the Regimen app.

Titration Schedule Planner

Plan your dose escalation timeline

Wegovy Schedule

Standard FDA titration schedule. Your provider may adjust based on your response.

How the Titration Planner Works

Select your medication

Choose from Wegovy, Ozempic, Mounjaro, Zepbound, or Retatrutide

Enter start date

When you started (or will start) your first dose

View your schedule

See exact dates for each dose increase

Copy or track

Copy schedule or track in the Regimen app

GLP-1 Dose Calculator

Calculate exact syringe units for compounded semaglutide or tirzepatide

Peptide Calculator

Calculate doses for BPC-157, TB-500, and other peptides

Data Sources

This tool uses dosing information from official prescribing information:

  • FDA Wegovy Prescribing Information - Official semaglutide (Wegovy) dosing and titration schedule
  • FDA Ozempic Prescribing Information - Official semaglutide (Ozempic) dosing and titration schedule
  • FDA Mounjaro Prescribing Information - Official tirzepatide (Mounjaro) dosing and titration schedule
  • FDA Zepbound Prescribing Information - Official tirzepatide (Zepbound) dosing and titration schedule
  • Retatrutide Phase 2 Trial Protocol (NCT04881760) - Investigational triple-agonist titration schedule from clinical trials

Get the app

Track your GLP-1 journey, not just the numbers

Regimen maps your titration timeline, reminds you when to step up, and logs your weight, side effects, and progress in one place. Free for one compound.

  • Visualize titration timeline
  • Smart injection reminders
  • Log weight, side effects, and progress
  • Private, secure health data

Free to download. Free for your first compound.

Regimen app Today view with doses and estimated levels

Questions

Frequently Asked Questions

Why do GLP-1 medications require dose titration?

Titration helps your body adjust gradually to the medication, minimizing side effects like nausea and GI discomfort. Starting at a lower dose and slowly increasing allows your system to adapt while still achieving therapeutic benefits.

What does a typical Ozempic titration schedule look like?

Ozempic (semaglutide) follows a 4-step titration: 0.25mg for weeks 1–4, then 0.5mg for weeks 5–8, then 1mg for weeks 9–12, and finally 2mg as the maintenance dose. Each step lasts 4 weeks to let your body adjust and minimize GI side effects. Your provider may extend any step if needed.

What does a typical Mounjaro titration schedule look like?

Mounjaro (tirzepatide (tirz)) uses a 6-step titration: 2.5mg for weeks 1–4, 5mg for weeks 5–8, 7.5mg for weeks 9–12, 10mg for weeks 13–16, 12.5mg for weeks 17–20, and 15mg as the maintenance dose. The gradual increase over ~20 weeks helps reduce nausea and other common side effects.

Can I skip titration steps or increase faster?

It's not recommended to skip steps without guidance from your healthcare provider. The titration schedule is designed to reduce side effects and improve tolerability. Your provider may adjust the pace based on how you respond.

What's the difference between Semaglutide and Tirzepatide?

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist. Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 agonist. Both are effective for weight management, but tirzepatide has shown slightly greater weight loss in clinical trials. Your provider can help determine which is best for you.

What if I miss a dose during titration?

If you miss a dose, take it as soon as you remember if it's within 5 days. If more than 5 days have passed, skip the missed dose and take your next scheduled dose. Don't double up. If you miss multiple doses, consult your provider about whether to restart titration.

How long does it take to reach maintenance dose?

For semaglutide, it typically takes 16-20 weeks to reach the 2.4mg maintenance dose. For tirzepatide, it takes about 20-24 weeks to reach 15mg. Your provider may adjust this timeline based on your response and goals.

What is Retatrutide?

Retatrutide is an investigational triple-agonist medication targeting GIP, GLP-1, and glucagon receptors. It's currently in clinical trials and not yet FDA-approved. The titration schedule shown is based on trial protocols and may change before approval.